Xiaobo Cai
- Hepatology top 5%
- Liver physiology and pathology 7
- Cancer Research top 10%
- MicroRNA in disease regulation 5
- Epidemiology top 10%
- Liver Disease Diagnosis and Treatment 13
-
- Gallbladder and Bile Duct Disorders 9
-
- Esophageal and GI Pathology 6
- Pediatric Hepatobiliary Diseases and Treatments 4
- Cholangiocarcinoma and Gallbladder Cancer Studies 4
-
- Pancreatic and Hepatic Oncology Research 3
- Co-authors
- Qidi ZhangYing QuMingyi XuLungen LuZhenzeng MaFei LiJian‐Gao FanYan Gao
- Journals
- Hepatology (1 paper)Biochemical and Biophysical Research Communications (1 paper)Frontiers in Microbiology (1 paper)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Xiaobo Cai
35 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 88
- Hepatology 248
- Complementary and Manual Therapy 45
- Cancer Research 239
- Epidemiology 444
- Endocrinology, Diabetes and Metabolism 155
Countries citing papers authored by Xiaobo Cai
This map shows the geographic impact of Xiaobo Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobo Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobo Cai more than expected).
Fields of papers citing papers by Xiaobo Cai
This network shows the impact of papers produced by Xiaobo Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobo Cai. The network helps show where Xiaobo Cai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaobo Cai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2023 | 27 | |
| 5 | 2022 | 2 | |
| 6 | 2022 | 81 | |
| 7 | 2021 | 8 | |
| 8 | 2020 | 1 | |
| 9 | 2020 | 1 | |
| 10 | 2019 | 13 | |
| 11 | 2019 | 39 | |
| 12 | 2018 | 17 | |
| 13 | 2016 | 4 | |
| 14 | 2016 | 7 | |
| 15 | 2015 | 4 | |
| 16 | 2015 | 40 | |
| 17 | 2014 | 42 | |
| 18 | 2014 | 13 | |
| 19 | 2012 | 21 | |
| 20 | 2007 | 37 |
About Xiaobo Cai
Xiaobo Cai is a scholar working on Hepatology, Epidemiology and Complementary and Manual Therapy, having authored 39 papers that have together received 1.1k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (13 papers), Gallbladder and Bile Duct Disorders (9 papers), Liver physiology and pathology (7 papers), Esophageal and GI Pathology (6 papers), MicroRNA in disease regulation (5 papers), Pediatric Hepatobiliary Diseases and Treatments (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). The work is most often cited by research in Hepatology (248 citations), Complementary and Manual Therapy (45 citations) and Cancer Research (239 citations). Xiaobo Cai has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Qidi Zhang, Ying Qu, Mingyi Xu, Lungen Lu, Zhenzeng Ma, Fei Li, Jian‐Gao Fan, Yan Gao, Yongde Peng and Fen Li. Their work appears in journals such as Hepatology, Biochemical and Biophysical Research Communications and Frontiers in Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.